Raphael Pharmaceutical (RAPH) Enterprise Value Growth (5y) (2025)
Raphael Pharmaceutical (RAPH) Enterprise Value Growth (5y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.42 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.71 Bn | 40.06 Bn | 2.15 Bn |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.41 Bn | 683.80 Mn |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.88% |